about
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.Deregulation of the activin/follistatin system in hepatocarcinogenesisVaults and the major vault protein: novel roles in signal pathway regulation and immunityConsequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosisAcquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expressionEffects of heavy water (D2O) on human pancreatic tumor cells.N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity.Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro.Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasisFibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.Apelin promotes lymphangiogenesis and lymph node metastasis.NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cellsSpatio-temporally precise activation of engineered receptor tyrosine kinases by light.Activins and follistatins: Emerging roles in liver physiology and cancerA bicistronic baculovirus vector for transient and stable protein expression in mammalian cells.Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.Light-assisted small-molecule screening against protein kinases.Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.The activin axis in liver biology and disease.In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axisCirculating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesotheliomaFibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy.Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis.Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance.Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation.Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.The effect of organic anion-transporting polypeptides 1B1, 1B3 and 2B1 on the antitumor activity of flavopiridol in breast cancer cells.Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.Activin A is anti-lymphangiogenic in a melanoma mouse model.Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.
P50
Q27853357-26FB05D7-B11F-4C8D-BADD-50C729DCB15DQ28260262-F9565754-2DC0-49B5-B87B-210710172F8AQ28292504-D1893B52-8FF1-4AF8-9157-AC30904DB65FQ28368232-CE65C4F7-D99F-440C-8632-DCB2A93B749FQ30365571-7542E593-B702-49FB-9DEA-85C21708F7CFQ33221723-B1C2287A-C531-46C3-A1A4-7813A7D52033Q33301354-FE16C634-A615-4C85-8044-6278F82194D8Q33304342-9E3F85FC-51E5-4945-BF68-4CBE51E83BB8Q33337158-028740B9-C3D7-4776-87AC-55840D47DDAEQ33566634-9AB4E116-3138-40C7-ADCE-B44D88CCB670Q33751398-4D0849D3-3844-4685-B942-F535F2D4E1CDQ33757125-AEA370D8-5522-49F5-9A53-31ABE972A053Q33783047-95514BB8-2974-48FD-946D-F60ECAAF62BBQ34100995-B4254740-C7AE-43C5-8595-CAFDECEB228CQ34188731-871CA3A2-1147-44BF-ADF1-F20E40F25543Q34324550-5BD727DE-A678-499C-B945-D4BAC6325DE8Q34391497-11C6F99D-8D62-41BF-B469-9B09500BC187Q34785518-DA976DA3-CFD0-4B55-ADB3-8F82F6C27240Q34806721-05EA2947-FED5-404E-8995-7C8D1F7D947DQ35025478-E963A875-3BF5-4889-9523-BF5FB2979750Q35678741-1D6E89DD-9227-4236-B572-39A0DFB02CDFQ35803232-E57A5138-119C-465C-8E73-C9D354FA02D6Q36059811-9C1C5CE5-6D96-4AD8-ADB9-F2750500FE24Q36081391-EBA3D60D-A396-4F1C-B405-0D093034A206Q36602213-B5C5E944-F5F6-4CAF-89B1-C31856ACE22EQ36671834-EF1653BC-CCF2-4D36-A872-00557F250ADAQ37420167-80687244-0FF4-4C28-B371-DFA3B7683AB8Q37594406-7BC61125-16D9-48BE-BBBB-F6A290E036B5Q37688471-EA3F1D7A-047F-4D87-9367-C391490CC7ABQ37849781-FDB9CA36-F43B-4EEA-8089-D12ED3913E56Q38710661-B4A6F47E-A8B8-4133-8043-C5C8C750EF32Q38720938-9117928F-F45E-4C41-911B-C4C547DDFAFFQ38752503-58F178A6-C8EC-4291-A756-610A0FE2F97CQ38848410-2B54C9D4-29AB-4F91-9EDF-D3C315F8483EQ38870822-FAD9D8D1-FCA4-4A60-BC89-CB12825A69BDQ38944385-EDC27B5B-E970-480D-BC8E-1417470663A5Q38949147-A626E211-3852-438F-AA39-8CF32546F2DBQ38959812-0C0A9F46-351F-4EEE-8075-DC7091F61995Q38969569-D561E12A-48A0-492D-BAE3-33D966B9A6CDQ38974755-F164BD24-26DE-44C4-A8C1-005E2520ED5E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael Grusch
@ast
Michael Grusch
@en
Michael Grusch
@es
Michael Grusch
@nl
Michael Grusch
@sl
type
label
Michael Grusch
@ast
Michael Grusch
@en
Michael Grusch
@es
Michael Grusch
@nl
Michael Grusch
@sl
prefLabel
Michael Grusch
@ast
Michael Grusch
@en
Michael Grusch
@es
Michael Grusch
@nl
Michael Grusch
@sl
P1053
C-1183-2008
P106
P21
P31
P3829
P3835
michael-grusch
P496
0000-0001-5486-9340